Exciting news ahead -
?
?
?We have made major advances in understanding the market opportunities in COPD diagnosis and forged new clinical relationships and collaborations (both within Australia and internationally) through participation in key respiratory disease meetings, including the Thoracic Society ANZ in Perth and the American Thoracic Society Meeting in Denver, USA.
?
Bringing all of the above developments together, we are currently sourcing and testing a range of clinical samples that should define Tyrian?s first proprietary point-of-care test got chronic lung disease".
chronic lung disease
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add APL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.908M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3167 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 19131 | 1 |
View Market Depth
| Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
| APL (ASX) Chart |
Day chart unavailable